Telo Genomics Corp (TSE:TELO) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Telo Genomics Corp. has received approval from the Intellectual Property Ontario Program, potentially securing up to CAD 80,000 for their IP costs. This support will bolster Telo’s growing patent portfolio, which includes technologies like the TeloViewSMM test for smoldering multiple myeloma, offering significant market potential.
For further insights into TSE:TELO stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue